← Browse by Condition
Medical Condition
advanced cholangiocarcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 3
NCT06439485 Phase 1, Phase 2
Recruiting
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
Enrollment
25 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05791448 Phase 1
Recruiting
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
Enrollment
36 pts
Location
United States
Sponsor
University of Southern Califor...
NCT05823311 Phase 3
Recruiting
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Enrollment
80 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...